MedPath

BILAXTEN 20 MG COMPRIMIDOS

BILAXTEN 20 MG COMPRIMIDOS

Commercialized
Register Number

34009_499_140_1_2_IP1

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Feb 25, 2020

Dosage Form

COMPRIMIDO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number34009_499_140_1_2_IP1
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

BILASTINAActive
Quantity: 20 mg
Name: BILASTINA

ATC CLASSIFICATION (3)

R06A
R06AX
R06AX29

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.